167 related articles for article (PubMed ID: 23325444)
1. Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.
Liu FY; Deng YL; Li Y; Zeng D; Zhou ZZ; Tian DA; Liu M
Med Oncol; 2013 Mar; 30(1):425. PubMed ID: 23325444
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
4. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
Ye WC; Gao L; Huang J; Fang XM; Xie G
Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
[TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma.
Sun Z; Han Q; Zhou N; Wang S; Lu S; Bai C; Zhao RC
Mol Oncol; 2013 Oct; 7(5):884-94. PubMed ID: 23684102
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
[TBL] [Abstract][Full Text] [Related]
10. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of RFX1 predicts poor prognosis of patients with small hepatocellular carcinoma.
Liu Y; Jiang P; Wang G; Liu X; Luo S
Eur J Surg Oncol; 2018 Jul; 44(7):1087-1093. PubMed ID: 29764705
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
14. Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.
Zhou P; Chen Z; Chang RM; Jiang W; Wu LL; Wang ZM
Med Oncol; 2012 Dec; 29(5):3063-9. PubMed ID: 22644917
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
17. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]